Renovorx to participate in march 2022 investor conferences

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its leadership's participation in two upcoming investor conferences this month. roth capital partners 34th annual conference format and dates: in person, march 13-15, 2022 location: the ritz carlton laguna niguel hotel, dana point, ca presenters and presentation date/time: shaun bagai, ceo, to present on monday, ma
RNXT Ratings Summary
RNXT Quant Ranking